Androgen suppression with abiraterone acetate, leuprolide, PARP inhibition, and stereotactic body radiotherapy (ASCLEPIuS) in high-risk and node positive prostate cancer (PCa): Phase I multicenter results Meeting Abstract
| Authors: | Jackson, W. C.; Dess, R. T.; Jia, A. Y.; Nagar, H.; Desai, N. B.; Hannan, R.; Hearn, J. W. D.; Reichert, Z. R.; Marciscano, A. E.; Davis, B.; Zuhour, R.; Zaorsky, N. G.; Garcia, J. A.; Barata, P. C.; Brown, J. R.; Mendiratta, P.; Feng, F. Y.; Chinnaiyan, A.; Suresh, K.; Spratt, D. E. |
| Abstract Title: | Androgen suppression with abiraterone acetate, leuprolide, PARP inhibition, and stereotactic body radiotherapy (ASCLEPIuS) in high-risk and node positive prostate cancer (PCa): Phase I multicenter results |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454758600007 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.387 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 387 -- Source: Wos |
